TherapeuticsMD, Inc.

TXMD

TherapeuticsMD, Inc.

TXMD

Insider Sentiment (TTM):

Last Purchase:2025-12-23Last Sale:2023-12-07Shares Purchased (TTM):8,400Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:3,921,239Shares Outstanding:11,574,000Institutional Ownership Pct.:33.88%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-06-30	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	-	8	-	7	6	6	5	5	4	-
Assets Current
Assets Current	16	15	14	15	13	13	12	12	12	17
Cash	-	-	-	-	-	-	-	-	4	10
Cash Equivalents At Carrying Value	9	8	7	-	-	-	5	-	-	-
Prepaid Expense And Other Assets Current	4	4	3	4	4	4	4	4	4	5
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	-	-	-	0	-
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	0
Intangible Assets Net Excluding Goodwill	4	4	4	4	4	4	4	5	6	7
Operating Lease Right Of Use Asset	5	5	5	6	6	6	6	6	7	7
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0
Assets	38	38	38	39	39	38	39	40	43	50
Liabilities And Stockhold…
Accounts Payable Current	0	0	0	0	0	0	0	0	0	1
Other Liabilities Current	-	-	-	-	-	-	-	-	-	7
Liabilities Current
Liabilities Current	5	5	5	5	5	5	5	6	7	15
Accounts Payable And Other Accrued Liabilities Cur…	-	-	-	-	-	-	-	3	3	-
Accrued Liabilities And Other Liabilities	2	2	2	2	2	2	2	-	3	-
Liabilities Of Disposal Group Including Discontinu…	3	3	3	3	3	3	3	3	4	7
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	6	7	-
Operating Lease Liability Noncurrent	5	5	5	5	6	6	6	-	7	7
Other Liabilities Noncurrent	1	1	1	1	1	1	1	1	1	1
Liabilities	10	11	11	11	11	11	11	12	14	22
Common Stock Value	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital Common Stock	979	979	979	979	979	979	979	979	979	977
Stockholders Equity	27	27	27	27	27	27	27	28	29	28
Retained Earnings Accumulated Deficit	-952	-952	-952	-952	-952	-952	-952	-951	-950	-949
Liabilities And Stockholders Equity	38	38	38	39	39	38	39	40	43	50
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	640	32	32	32	32	32	32	32	12	32
Common Stock Shares Issued	12	12	12	12	12	12	12	12	12	11
Shares Outstanding	12	12	12	12	12	12	12	12	12	11

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.05%	8.21%	4.10%	-	-	-	-	-	-	-	-	-
2025	-17.76%	-22.37%	-26.97%	-2.70%	-3.60%	7.21%	3.57%	-1.79%	28.57%	10.05%	6.53%	-2.01%
2024	-	-	-	3.59%	-1.80%	-7.19%	-	-	-	-3.81%	42.86%	11.43%
2023	-	-	-	-6.49%	-25.97%	-42.60%	3.48%	13.43%	12.94%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-06-30	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.22	3.11	3.02	2.93	2.89	2.64	2.37	2.03	1.72	1.20
Quick Ratio	2.52	2.37	2.30	2.18	2.10	1.84	1.67	1.40	1.13	0.89
Working Capital	11.12M	10.35M	9.66M	9.56M	8.80M	7.77M	7.09M	6.01M	4.94M	2.93M
Leverage & Debt
Debt to Equity	0.38	0.39	0.40	0.41	0.41	0.43	0.42	0.45	0.48	0.80
Interest Coverage TTM	-1,317.67	-766.40	-627.14	-405.43	-529.44	-811.57	-246.92	-123.50	-74.11	361.13
Debt Ratio	0.28	0.28	0.29	0.29	0.29	0.30	0.29	0.31	0.32	0.44
Efficiency & Turnover
Asset Turnover TTM	0.09	0.09	0.08	0.05	0.04	0.03	0.01	0.02	0.02	0.75
Per Share Metrics
Diluted EPS TTM	-0.02	0.02	-0.05	0.00	-0.10	-0.23	-0.46	-0.67	-0.98	6.38
Free Cash Flow Per Share TTM	0.25	0.23	0.21	0.12	0.14	-0.26	-0.85	-1.90	-3.04	0.31
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	100.00%	79.14%
Operating Profit Margin TTM	-120.89%	-114.29%	-145.27%	-133.30%	-301.77%	-503.19%	-903.81%	-771.88%	-654.61%	59.87%
Net Profit Margin TTM	-6.64%	5.34%	-18.83%	2.35%	-75.49%	-232.60%	-783.46%	-693.30%	-789.40%	98.47%
Growth Metrics
Net Revenue Growth (1Y)	107.09%	196.99%	342.46%	90.09%	21.27%	-98.37%	-99.02%	-98.39%	-98.14%	-207.87%
Net Income Growth (1Y)	-81.80%	-106.82%	-89.37%	-100.64%	-88.40%	-103.84%	-112.53%	-104.93%	-109.18%	-888.31%
EPS Growth (1Y)	-81.80%	-106.80%	-89.40%	-100.64%	-89.54%	-103.56%	-111.10%	-104.17%	-107.94%	-782.23%
Valuation Metrics
P/E TTM	-117.87	130.61	-33.14	250.00	-11.26	-4.09	-1.85	-2.39	-2.29	0.47
P/B TTM	0.94	0.87	0.70	0.46	0.49	0.40	0.36	0.67	0.80	1.15
P/S TTM	7.82	6.97	6.24	5.87	8.50	9.52	14.52	16.58	18.04	0.47
Market Cap	25.58M	23.38M	18.86M	12.50M	13.43M	10.74M	9.92M	18.57M	23.49M	32.32M
Enterprise Value	16.39M	14.96M	11.37M	5.38M	7.36M	5.00M	4.86M	13.33M	19.17M	-17.00M
Calculated Values
Free Cash Flow TTM	2.85M	2.70M	2.45M	1.38M	1.61M	-3.04M	-9.76M	-21.86M	-31.78M	3.32M
Net Debt	-9.19M	-8.42M	-7.48M	-7.12M	-6.07M	-5.75M	-5.06M	-5.23M	-4.33M	-49.32M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-23Purchase

Owner: Thompson, Tommy G

Title: -

Shares: 8,400

Price/Share: $1.67

Value: $14,028.00

Shares Owned: 23,179

Relationship: Director

Ownership: Direct

2025-04-14Purchase

Owner: Walker, Marlan D

Title: Chief Executive Officer

Shares: 490

Price/Share: $1.00

Value: $490.00

Shares Owned: 73,639

Relationship: Officer

Ownership: Direct

2025-04-14Purchase

Owner: Thompson, Tommy G

Title: -

Shares: 325

Price/Share: $1.00

Value: $325.00

Shares Owned: 14,779

Relationship: Director

Ownership: Direct

2025-04-10Purchase

Owner: Walker, Marlan D

Title: Chief Executive Officer

Shares: 1,167

Price/Share: $0.86

Value: $1,003.62

Shares Owned: 73,149

Relationship: Officer

Ownership: Direct

2024-08-22Purchase

Owner: Collins, Cooper C.

Title: -

Shares: 4,094

Price/Share: $1.73

Value: $7,082.62

Shares Owned: 52,016

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-23	Thompson, Tommy G	Director	-	Direct	Purchase	8,400	1.67	$14,028.00	23,179	4
2025-04-14	Walker, Marlan D	Officer	Chief Executive Officer	Direct	Purchase	490	1.00	$490.00	73,639	4
2025-04-14	Thompson, Tommy G	Director	-	Direct	Purchase	325	1.00	$325.00	14,779	4
2025-04-10	Walker, Marlan D	Officer	Chief Executive Officer	Direct	Purchase	1,167	0.86	$1,003.62	73,149	4
2024-08-22	Collins, Cooper C.	Director	-	Direct	Purchase	4,094	1.73	$7,082.62	52,016	4
2024-08-21	Collins, Cooper C.	Director	-	Direct	Purchase	1,200	1.70	$2,040.00	47,922	4
2023-12-07	Walker, Marlan D	Officer	Chief Executive Officer	Direct	Sale	4,550	2.24	$10,192.00	62,565	4
2023-04-26	Walker, Marlan D	Officer	Chief Executive Officer	Direct	Sale	692	3.64	$2,518.88	11,615	4/A
2023-04-12	Walker, Marlan D	Officer	Chief Executive Officer	Direct	Sale	1,170	3.65	$4,270.50	12,307	4
2023-01-27	Donegan, Michael C	Officer	Prin. Fin. and Acctg. Officer	Direct	Sale	49	5.09	$249.41	11,853	4
2023-01-24	Donegan, Michael C	Officer	Prin. Fin. and Acctg. Officer	Direct	Sale	7	5.31	$37.17	7,610	4
2022-12-30	Rubric, Capital Managemen…	TenPercentOwner	-	Indirect	Sale	29,000	1333.00	$38,657,000.00	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

33.88%

Inst. Shares: 3,921,239

Shares Outstanding: 11,574,000

2025-12-31

29.26%

Inst. Shares: 3,384,889

Shares Outstanding: 11,569,000

2025-09-30

28.54%

Inst. Shares: 3,303,767

Shares Outstanding: 11,574,000

2025-06-30

28.12%

Inst. Shares: 3,254,871

Shares Outstanding: 11,574,000

2025-03-31

28.94%

Inst. Shares: 3,343,569

Shares Outstanding: 11,552,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	3,921,239	11,574,000	33.88%
2025-12-31	3,384,889	11,569,000	29.26%
2025-09-30	3,303,767	11,574,000	28.54%
2025-06-30	3,254,871	11,574,000	28.12%
2025-03-31	3,343,569	11,552,000	28.94%
2024-12-31	3,528,735	11,532,000	30.60%
2024-09-30	3,378,926	11,532,000	29.30%
2024-06-30	3,408,549	11,532,000	29.56%
2024-03-31	3,362,269	10,441,000	32.20%
2023-12-31	3,250,848	10,441,000	31.14%
2023-09-30	2,986,536	10,701,000	27.91%
2023-06-30	3,030,183	10,219,000	29.65%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

TherapeuticsMD, Inc. (TXMD) — SEC Financial Statements & Analysis

TherapeuticsMD, Inc. (TXMD) is a pharmaceutical preparations company, incorporated in NV. TherapeuticsMD, Inc. trades on Nasdaq as: TXMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), TherapeuticsMD, Inc. reported a 107.09% year-over-year revenue growth, a Gross Profit Margin of 100.00% (TTM), a Debt-to-Equity ratio of 0.38x, a Price-to-Sales (P/S) ratio of 7.82x (TTM), a Price-to-Book (P/B) ratio of 0.94x (TTM), at a market cap of $25.58M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 107.09%
Gross Profit Margin TTM: 100.00%
Debt To Equity: 0.38x
P/S TTM: 7.82x
P/B TTM: 0.94x
Market Cap: $25.58M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TherapeuticsMD, Inc. in?

TherapeuticsMD, Inc. (TXMD) operates in the Pharmaceutical Preparations industry.

What is TXMD's market cap?

TherapeuticsMD, Inc. (TXMD) has a market capitalization of $25.58M as of 2026-06-30.

What exchange does TXMD trade on?

TherapeuticsMD, Inc. (TXMD) trades on the Nasdaq.

Where is TherapeuticsMD, Inc. incorporated?

TherapeuticsMD, Inc. is incorporated in NV.